Trials demonstrated adequate tolerance in therapeutic doses, but other complications have also been described aside from hemolysis in G6PD-deficient patients, such as hemolysis in non-G6PD-deficient individuals, mild or self-limited methemoglobinemia, gastrointestinal complaints, and allergies.11 Here, G6PD is linked to methemoglobinemia.